Exploration of Vitamin D Supplementation Adjuvant Therapy for Childhood Asthma and the Best Treatment Options

Zhendong Yang; Xuding Sun; Jihong Wu; Gaojun Zhou; Yingyang Xu; Xiong Xie; Kai Guan

doi:doi:10.11648/j.ajp.20190504.32

| Peer-Reviewed

Exploration of Vitamin D Supplementation Adjuvant Therapy for Childhood Asthma and the Best Treatment Options

Zhendong Yang, Xuding Sun, Jihong Wu, Gaojun Zhou, Yingyang Xu, Xiong Xie, Kai Guan

Published in American Journal of Pediatrics (Volume 5, Issue 4)

Received: 12 November 2019 Accepted: 12 December 2019 Published: 24 December 2019

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Vitamin D not only promotes the health of human bones and muscles but also has an important impact on the metabolism of extraskeletal tissues. As a steroid hormone, vitamin D possesses important physiological functions, including cell differentiation and proliferation and immune regulation. Research has shown that vitamin D insufficiency (VDI) or vitamin D deficiency (VDD) can make children susceptible to asthma. Vitamin D has important immunoregulatory functions associated with preventing the occurrence of asthma or the worsening of its symptoms, improving lung function and enhancing glucocorticoid (GCS) action. An increasing number of randomized controlled intervention studies have confirmed that vitamin D affects the occurrence and development of asthmatic diseases. In recent years, accumulating laboratory and clinical research has supported the use of vitamin D as an adjuvant treatment for asthma and has achieved good clinical results. But the clinical outcome of vitamin D in the treatment of asthma is not as impressive as experimental studies. In addition to the complexity of clinical research, it may be related to clinical application methods. In order to combine theory with clinical practice, focused on exploring and selecting the most effective vitamin D adjuvant treatment of asthma, and comprehensively optimizing and applying these methods is beneficial to improve the therapeutic effect. However, there are different opinions regarding the results of the studies.

Published in	American Journal of Pediatrics (Volume 5, Issue 4)
DOI	10.11648/j.ajp.20190504.32
Page(s)	291-298
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2019. Published by Science Publishing Group

Keywords

Vitamin D, VDD, Asthma, Children, Vitamin D Adjuvant Therapy

References

[1]	Banno, A., A. T. Reddy, S. P. Lakshmi, and R. C. Reddy (2018). PPARs: Key Regulators of Airway Inflammation and Potential Therapeutic Targets in Asthma. Nucl. Receptor Res. 5, 101306.
[2]	Wolsk, H. M., B. L. Chawes, A. A. Litonjua, B. W. Hollis, J. Waage, J. Stokholm, K. Bønnelykke, H. Bisgaard, and S. T. Weiss (2017). Prenatal vitamin D supplementation reduces risk of asthma/recurrent wheezein early childhood: A combined analysis of two randomized controlled trials. PLoS One. 27, 12 (10): e0186657.
[3]	Hossein-nezhad, A., andM. F. Holick (2013). Vitamin D for health: A global perspective. Mayo Clin. Proc. 88, 720–755.
[4]	Hossein-nezhad, A., A. Spira, and M. F. Holick (2013). Influence of vitamin D status andvitaminD3 supplementation on genome wide expression of white blood cells: A randomized double-blind clinical trial. PLoS One. 8, e58725.
[5]	Han, J. C., J. Du, Y. J. Zhang, G. B. Qi, H. B. Li, Y. J. Zhang, andX. L. Yu (2016). Vitamin D receptor polymorphisms may contribute to asthma risk. J. Asthma. 53 (8), 790-800.
[6]	Tizaoui, K., A. Berraies, B. Hamdi, W. Kaabachi, K. Hamzaoui, and A. Hamzaoui (2014). Association of vitamin D receptor gene polymorphisms with asthma risk: systematic review and updated meta-analysis of case-control studies. Lung. 192 (6), 955-65.
[7]	li, F., L. Jiang, S. A. Willis-Owen, Y. Zhang, and J. Gao (2011). Vitamin D binding protein variants associate with asthma susceptibility in the Chinese Han population. B. M. C. Med. Genet. 12, 10
[8]	Hutchinson, K., C. P. Kerley, J. Faul, P. Greally, D. Coghlan, M. Louw, B. Elnazir, andY. Rochev (2018). Vitamin D receptor variants and uncontrolled asthma. Eur. Ann. Allergy Clin. Immunol. 50 (3), 108-116.
[9]	Overbergh, L., B. Decallonne, D. Valckx, A. Verstuyf, J. Depovere, J. Laureys, Q. Rutgeerts, R. Saint-Arnaud, R. Bouillon, and C. Mathieu (2000). Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin. Exp. Immunol. 120, 139e46.
[10]	Sutherland, E. R., E. Goleva, L. P. Jackson, A. D. Stevens, and D. Y. Leung (2010). Vitamin D levels, lung function, and steroid response in adult asthma. Am. J. Respir. Crit. care Med. 181, 699e704.
[11]	Mu, A. C., K. Tantisira, L. Li, A. L. Fuhlbrigge, S. T. Weiss, and A, Litonjua (2012). Effect of vitamin D and inhaled corticosteroid treatment on lung function in children. Am. J. Respir. Crit. Care Med. 15; 186 (6), 508-13.
[12]	Wei, R., and S. Christakos (2015). Mechanisms underlying the regulation of innate and adaptive immunity by vitamin D. Nutrients. 7（10）, 8251-8260.
[13]	Xystrakis, E., I. Siddharth, C. Pridgeon, M. Dallman, T. K. Loke, D. S. Robinson, F. J. Barrat, A. O’Garra, P. Lavender, T. H. Lee, C. Corrigan, and C. M. Hawrylowicz (2006). Reversing the defective induction of IL-10–secreting regulatory T cells in glucocorticoid-resistant asthma patients. J. Clin. Invest. 4; 116 (1), 146-155.
[14]	Litonjua, A. A (2019). Vitamin D and childhood asthma: causation and contribution to disease activity. Curr. Opin. Allergy Clin. Immunol. 19 (2), 126-131.
[15]	Kang, Q., X. Zhang, S. Liu, and F. Huang (2018). Correlation between the vitamin D levels and asthma attacks in children: Evaluation of the effects of combination therapy of atomization inhalation of budesonide, albuterol and vitamin D supplementation on asthmatic patients. Exp. Ther. Med. 15 (1), 27-732.
[16]	Manousaki, D., L. Paternoster, M. Standl, M. F. Moffatt, M. Farrall, E. Bouzigon, D. P. Strachan, F. Demenais, M. Lathrop, W. O. C. M. Cookson, J. B. Richards, D. Manousaki, L. Paternoster, M. Marie Standl, M. F. Moffatt, M. MartinFarrall, E. Bouzigon, D. P. Strachan, F. Florence Demenais, M. Mark Lathrop, W. O. C. M. William Cookson, and B. Brent Richards (2017). Vitamin D levels and susceptibility to asthma, elevated immunoglobulin E levels, and atopic dermatitis: A Mendelian randomization study. PLoS Med. 14 (5), e1002294.
[17]	Riverin, B. D., J. L. Maguire, and P. Li (2015). Vitamin D Supplementation for Childhood Asthma: A Systematic Review and Meta-Analysis. PLoS One. 10 (8), e0136841.
[18]	Zhen-Dong, Yang., and Guo-Wei Song (2018). Research progress on the role of vitamin D in respiratory tract infection in children. Chin. J. Appl. Clin. Pediatr. 33 (16), 74-78.
[19]	Holick, M. F., N. C. Binkley, H. A. Bischoff-Ferrari, C. M. CGordon, D. A. Hanley, P. Robert. R. P. Heaney, M. H. Murad, and C. M. Weave (2011). Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 96 (7), 1911–1930.
[20]	Ross, A. C., J. E. Manson, S. A. Abrams, J. F. Aloia, P. M. Brannon, S. K. Clinton, R. A. Durazo-Arvizu, J. C. Gallagher, R. L. Gallo, G. Jones, C. S. Kovacs Mayne, C. J. Rosen, and S. A. Shapses (2011). The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know. J. Clin. Endocrinol. Metab. 96 (1), 53–58.
[21]	Saggese, G., F. Vierucci, F. Prodam, F. Cardinale, I. Cetin, E. Chiappini, G. L. de’Angelis, M. Massari, E. M. D. Giudice, D. Peroni, L. Terraccia o, R. Agostiniani, D. Careddu, D. G. Ghiglioni, G. Bona, G. D. Mauro, and G. Corsello (2018). Vitamin D in pediatric age: consensus of the Italian Pediatric Society and the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Federation of Pediatricians. Ital. J. Pediatr. 44, 51.
[22]	Rusińska, A., P. Płudowski, M. Walczak, M. K. Borszewska-Kornacka, A. Bossowski, D. Chlebna-Sokół, J. Czech-Kowalska, A. Dobrzańska, E. Franek, E. Helwich, T. Jackowska, M. A. Kalina, J. Konstantynowicz, J. Książyk, A. Lewiński, J. Łu aszkiewicz, E. Marcinowska-Suchowierska, A. Mazur, I. Michałus, J. Peregud-Pogorzelski, H. Romanowska, M. Ruchała, P. Socha, M. Szalecki, M. Wielgoś, D. Zwolińska, andA. Zygmunt (2018). Vitamin D Supplementation Guidelines for General Population and Groups at Risk of Vitamin D Deficiency in Poland—Recommendations of the Polish Society of Pediatric Endocrinology and Diabetes and the Expert Panel With Participation of National Specialist Consultants and Representatives of Scientific Societies—2018 Update. Front Endocrinol. 31, 9:246.
[23]	Spedding, S., S. Vanlint, H. Morris, and R. Scragg (2013). Vitamin D Sufficiency Equate to a Single Serum 25-Hydroxyvitamin D Level or Are Different Levels Required for Non-Skeletal Diseases?. Nutrients. 16, 5 (12): 5127-39.
[24]	Han, Y. Y., E. Forno, and J. C. Celedon (2017). Vitamin D insufficiency and asthma in a US nationwide study. J. Allergy Clin. Immunol. Pract. 5 (3), 790-796. e1.
[25]	Man, L., Z. Zhang, M. Zhang, Y. Zhang, J. Li, N. Zheng, Y. Cao, M. Chi, Y. Chao, Q. Huang, C. Song, and B. Xu (2015). Association between vitamin D deficiency and insufficiency and the risk of childhood asthma: evidence from a meta-analysis. Int. J. Cli. Exp. Med. 8 (4), 5699–5706.
[26]	Solidoro, P., M. Bellocchia, I. Aredano, A. Mattei, E. Pivetta, F. Patrucco, M. Boita, F. de Blasio, L. Brussino, G. Rolla, and C. Bucca (2017). Asthmatic Patients with Vitamin D Deficiency have Decreased Exacerbations after Vitamin Replacement. Nutrients. 9 (11), 1234.
[27]	Arikoglu, T., S. Kuyucu, E. Karaismailoglu, S. B. Batmaz, and S. Balci (2015). The association of vitamin D, cathelicidin, and vitamin D binding protein with acute asthma attacks in children. Allergy Asthma Proc. 36, 51–8.
[28]	Lan, N., G. Luo, X. Yang, Y. Cheng, Y. Zhang, X. Wang, X. Wang, T. Xie, G. Li, Z. Liu, and N. Zhong (2014). 25-Hydroxyvitamin D3-deficiency enhances oxidative stress and corticosteroid resistance in severe asthma exacerbation. PLoS One. 9 (11), e111599.
[29]	Afzal, S., P. Lange, S. E. Bojesen, J. J. Freiberg, and B. G. Nordestgaard (2014). Plasma 25-hydroxyvitamin D, lung function and risk of chronic obstructive pulmonary disease. Thorax. 69, 24e31.
[30]	Mirzakhani, H., V. J. Carey, R. Zeiger, L. B. Bacharier, G. T. O’Connor, M. X. Schatz, N. Laranjo, S. T. Weiss, A. A. Litonjua (2019). Impact of Parental Asthma, Prenatal Maternal Asthma Control and Vitamin D Status on Risk of Asthma and Recurrent Wheeze in 3-Year Old Children. Clin. Exp. Allergy. 49 (4), 419–429.
[31]	Vahdaninia, M., H. Mackenzie, S. Helps, and T. Dean (2017). Prenatal Intake of Vitamins and Allergic Outcomes in the Offspring: A Systematic Review and Meta-Analysis. J. Allergy Clin. Immunol. Pract. 5 (3), 771-778.
[32]	Feng, H., P. Xun, K. Pike, B. L. Chawes, H. Bisgaard, W. Cai, Y. Wan, and K. He (2017). In utero exposure to 25-hydroxyvitamin D and risk of childhood asthma, wheeze, and respiratory tract infections: A meta-analysis of birth cohort studies. J. Allergy Clin. Immunol. 139 (5), 1508-1517.
[33]	Majak, P., M. Olszowiec-Chlebna, and K. Smejda (2011). Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. J. Allergy Clin. Immunol. 127 (5), 1294-6.
[34]	Jolliffe, D. A., L. Greenberg, R. L. Hooper, C. J. Griffiths, C. A. M. D. Camargo, C. P. Kerley, M. E. Jensen, D. Mauger, I. Stelmach, M. Urashima, and A. R. Martineau (2017). Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data. Lancet Respir. Med. 5 (11), 881–890.
[35]	Tachimoto, H., H. Mezawa, T. Segawa, N. Akiyama, H. Ida, andM. Urashima (2016). Improved control of childhood asthma with low-dose, short-term vitamin D supplementation: a randomized, double-blind, placebo-controlled trial. Allergy. 71 (7), 1001-9.
[36]	Hollams, EM., H. M. Teo, M. Kusel, B. J. Holt, K. E. Holt, M. Inouye, N. H. De Klerk, G. Zhang, P. D. Sly, P. H. Hart, and P. G. Holt (2017). Vitamin D over the first decade and susceptibility to childhood allergy and asthma. J. Allergy Clin. Immunol. 139 (2), 472-481.
[37]	Pojsupap, S., K. Iliriani, T. Z. Sampaio, K. O'Hearn, T. Kovesi, K. Menon, and J. D. McNally (2015). Efficacy of high-dose vitamin D in pediatric asthma: a systematic review and meta-analysis. J. Asthma. 52 (4), 382-90.
[38]	Bose, S., G. B. Diette, H. Woo, K. Koehler, K. Romero, A. M. Rule, B. Detrick, E. Brigham, M. C. McCormack, and N. N. Hansel (2019). Vitamin D status modifies the response to indoor particulate matter in obese urban children with asthma. J. Allergy Clin. Immunol. Pract. 11. pii, S2213-2198 (19)30160-6.
[39]	Haq, A., S. J. Wimalawansa, P. Pludowski, and F. A. Anouti (2018). Clinical practice guidelines for vitamin D in the United Arab Emirates. J. Steroid Biochem. Mol. Biol. 175, 4-11.
[40]	Pludowski, P., M. F. Holick, W. B. Grant W, J. Konstantynowicz, M. R. Mascarenhas, A. V. Povoroznyuk, N. Balatska, A. P. Barbos, T. Karonova, E. Rudenka, W. Misiorowski, I. Zakharova, A. Rudenka, J. Łukaszkiewicz, E. Marcinowska-Suchowierska, N. Łaszcz, P. Abramowicz, H. P. Bhattoa, and S. J. Wimalawansa (2018). Vitamin D supplementation guidelines. J. Steroid Biochem. Mol. Biol. 175, 125-135.
[41]	Pfeffer, PE., M. Catherine, and C. M. Hawrylowicz (2018). Vitamin D in Asthma:Mechanisms of Action and Considerations for Clinical Trials. Chest. 153 (5), 1229-1239.
[42]	Mohamed, WA., and M. A. Al-Shehri (2013). Cord Blood 25-Hydroxyvitamin D Levels and the Risk of Acute Lower Respiratory Tract Infection in Early Childhood. J. Trop Pediatr. 59 (1), 29-35.
[43]	Majak, P., J. Jerzyńska, K. Smejda, I. Stelmach, D. Timle, and W. Stelmach ( 2012). Correlation of Vitamin D with Foxp3 induction and steroid-sparing effect of immunotherapy in asthmatic children．Ann. Allerge asthma immunol. 109, 329e35.
[44]	Lewis, E., C. Fernandez, A. Nella, R. Hopp, J. C. Gallagher, and T. B. Casale (2012). Relationship of 25-hydroxyvitamin D and asthma control in children. Ann. Allergy Asthma. Immunol. 108 (4), 281-282.
[45]	Martineau, A. R., D. A. Jolliffe, L. Greenberg, J. F. Aloia, P. Bergman, G. Dubnov-Raz, S. Esposito, D. Ganmaa, A. A. Ginde, E. C. Goodall, C. C. Grant, W. Janssens, M. E. Jensen, C. P. Kerley, I. Laaksi, S. Manaseki-Holland, D. Mauger, D. R. Murdoch, R. Neale, J. R. Rees, S. Simpson, I. Stelmach, G. Trilok Kuma, M. Urashima, C. A. Camargo, C. J. Griffiths, and R. L. Hooper (2019). Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis. Health Technol. Assess. 23 (2), 1-44.
[46]	Martineau, A. R., B. D. MacLaughlin, R. L. Hooper, N. C. Barnes, D. A. Jolliffe, C. L. Greiller, K. Kilpin, D. McLaughlin, G. Fletcher, C. A. Mein, M. Hoti, R. Walton, J. Grigg, P. M. Timms, R. K. Rajakulasingam, A. Bhowmik, M. Rowe, T. R. Venton, A. B. Choudhury, D. E. Simcock, Z. Sadique, W. R. Monteiro, C. J. Corrigan, C. M. Hawrylowicz, and C. J. Griffiths (2015). Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3supplementation in adults with asthma (ViDiAs). Thorax. 70 (5), 451-7.
[47]	Canguvena, O., W. E. Ansarib, andA. Yassinc (2018). Vitamin D supplementation as a potential therapeutic mediator in asthma: does dose really matter? A critical review of the literature. J. Aging Male. 29, 1-8.
[48]	Bergman, P., A. C. Norlin, S. Hansen, R. S. Rekha, B. Agerberth, L. Björkhem-Bergman, L. Ekström, J. D. Lindh, and J. Andersson (2012). Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study. B. M. J. Open. 2 (6) pii, e001663.
[49]	Yadav, M., and K. Mittal (2014). Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian. J. Pediatr. 81 (7), 650-4.
[50]	Bolcas, P. E., E. B. Brandt, Z. Zhang, J. M. Biagini Myers, B. P. Ruff, and G. K. Khurana Hershey (2019). Vitamin D supplementation attenuates asthma development following traffic-related particulate matter exposure. J. Allergy Clin. Immunol. 143 (1), 386-394. e3.
[51]	Tse, S. M., H. W. Kelly, A. A. Litonjua, M. L. Van Natta, S. T. Weiss, and K. G. Tantisira (2012). Corticosteroid use and bone mineral accretion in children with asthma: effect modification by vitaminD. J. Allergy Clin. Immunol. 130 (1), 53-60. e4.
[52]	Ramos-Martíneza, E., M. R. López-Vancella, J. C. Fernández de Córdova-Aguirreb, J. Rojas-Serranoc, A. Chavarríaa, A. Velasco-Medinab, and G. Velázquez-Sámanob (2018). Reduction of respiratory infections in asthma patients supplemented with vitamin D is related to increased serum IL-10 and IFNγ levels and cathelicidin expression. Cytokine. 108, 239-24.
[53]	Litonjua, A. A (2013). Vitamin D and corticosteroids in asthma: synergy, interaction and potential therapeutic effects. Expert. Review of Respiratory Medicine. 7 (2), 101-104.
[54]	Mehta, A. A., A. D. Agrawal, V. Appanna, and K. K. Chaudagar (2015). Vitamin D improves corticosteroid efficacy and attenuates its side-effects in an animal model of asthma. Can. J. Physiol. Pharmacol. 93 (1), 53-61.

Cite This Article

Plain Text BibTeX RIS

APA Style

Zhendong Yang, Xuding Sun, Jihong Wu, Gaojun Zhou, Yingyang Xu, et al. (2019). Exploration of Vitamin D Supplementation Adjuvant Therapy for Childhood Asthma and the Best Treatment Options. American Journal of Pediatrics, 5(4), 291-298. https://doi.org/10.11648/j.ajp.20190504.32

Copy | Download

ACS Style

Zhendong Yang; Xuding Sun; Jihong Wu; Gaojun Zhou; Yingyang Xu, et al. Exploration of Vitamin D Supplementation Adjuvant Therapy for Childhood Asthma and the Best Treatment Options. Am. J. Pediatr. 2019, 5(4), 291-298. doi: 10.11648/j.ajp.20190504.32

Copy | Download

AMA Style

Zhendong Yang, Xuding Sun, Jihong Wu, Gaojun Zhou, Yingyang Xu, et al. Exploration of Vitamin D Supplementation Adjuvant Therapy for Childhood Asthma and the Best Treatment Options. Am J Pediatr. 2019;5(4):291-298. doi: 10.11648/j.ajp.20190504.32

Copy | Download

@article{10.11648/j.ajp.20190504.32,
  author = {Zhendong Yang and Xuding Sun and Jihong Wu and Gaojun Zhou and Yingyang Xu and Xiong Xie and Kai Guan},
  title = {Exploration of Vitamin D Supplementation Adjuvant Therapy for Childhood Asthma and the Best Treatment Options},
  journal = {American Journal of Pediatrics},
  volume = {5},
  number = {4},
  pages = {291-298},
  doi = {10.11648/j.ajp.20190504.32},
  url = {https://doi.org/10.11648/j.ajp.20190504.32},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajp.20190504.32},
  abstract = {Vitamin D not only promotes the health of human bones and muscles but also has an important impact on the metabolism of extraskeletal tissues. As a steroid hormone, vitamin D possesses important physiological functions, including cell differentiation and proliferation and immune regulation. Research has shown that vitamin D insufficiency (VDI) or vitamin D deficiency (VDD) can make children susceptible to asthma. Vitamin D has important immunoregulatory functions associated with preventing the occurrence of asthma or the worsening of its symptoms, improving lung function and enhancing glucocorticoid (GCS) action. An increasing number of randomized controlled intervention studies have confirmed that vitamin D affects the occurrence and development of asthmatic diseases. In recent years, accumulating laboratory and clinical research has supported the use of vitamin D as an adjuvant treatment for asthma and has achieved good clinical results. But the clinical outcome of vitamin D in the treatment of asthma is not as impressive as experimental studies. In addition to the complexity of clinical research, it may be related to clinical application methods. In order to combine theory with clinical practice, focused on exploring and selecting the most effective vitamin D adjuvant treatment of asthma, and comprehensively optimizing and applying these methods is beneficial to improve the therapeutic effect. However, there are different opinions regarding the results of the studies.},
 year = {2019}
}

Copy | Download

TY  - JOUR
T1  - Exploration of Vitamin D Supplementation Adjuvant Therapy for Childhood Asthma and the Best Treatment Options
AU  - Zhendong Yang
AU  - Xuding Sun
AU  - Jihong Wu
AU  - Gaojun Zhou
AU  - Yingyang Xu
AU  - Xiong Xie
AU  - Kai Guan
Y1  - 2019/12/24
PY  - 2019
N1  - https://doi.org/10.11648/j.ajp.20190504.32
DO  - 10.11648/j.ajp.20190504.32
T2  - American Journal of Pediatrics
JF  - American Journal of Pediatrics
JO  - American Journal of Pediatrics
SP  - 291
EP  - 298
PB  - Science Publishing Group
SN  - 2472-0909
UR  - https://doi.org/10.11648/j.ajp.20190504.32
AB  - Vitamin D not only promotes the health of human bones and muscles but also has an important impact on the metabolism of extraskeletal tissues. As a steroid hormone, vitamin D possesses important physiological functions, including cell differentiation and proliferation and immune regulation. Research has shown that vitamin D insufficiency (VDI) or vitamin D deficiency (VDD) can make children susceptible to asthma. Vitamin D has important immunoregulatory functions associated with preventing the occurrence of asthma or the worsening of its symptoms, improving lung function and enhancing glucocorticoid (GCS) action. An increasing number of randomized controlled intervention studies have confirmed that vitamin D affects the occurrence and development of asthmatic diseases. In recent years, accumulating laboratory and clinical research has supported the use of vitamin D as an adjuvant treatment for asthma and has achieved good clinical results. But the clinical outcome of vitamin D in the treatment of asthma is not as impressive as experimental studies. In addition to the complexity of clinical research, it may be related to clinical application methods. In order to combine theory with clinical practice, focused on exploring and selecting the most effective vitamin D adjuvant treatment of asthma, and comprehensively optimizing and applying these methods is beneficial to improve the therapeutic effect. However, there are different opinions regarding the results of the studies.
VL  - 5
IS  - 4
ER  -

Copy | Download

Author Information

Zhendong Yang

Department of Respiratory Asthma, Beijing Jingdu Children's Hospital, Beijing, China
Xuding Sun

Department of Respiratory Asthma, Beijing Jingdu Children's Hospital, Beijing, China
Jihong Wu

Department of Respiratory Asthma, Beijing Jingdu Children's Hospital, Beijing, China
Gaojun Zhou

Department of Respiratory Asthma, Beijing Jingdu Children's Hospital, Beijing, China
Yingyang Xu

Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
Xiong Xie

Department of Pediatrics, Third Clinical Medical College of Three Gorges University (Gezhouba Central Hospital), Yichang, China
Kai Guan

Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Zhendong Yang, Xuding Sun, Jihong Wu, Gaojun Zhou, Yingyang Xu, et al. (2019). Exploration of Vitamin D Supplementation Adjuvant Therapy for Childhood Asthma and the Best Treatment Options. American Journal of Pediatrics, 5(4), 291-298. https://doi.org/10.11648/j.ajp.20190504.32

Copy | Download

ACS Style

Zhendong Yang; Xuding Sun; Jihong Wu; Gaojun Zhou; Yingyang Xu, et al. Exploration of Vitamin D Supplementation Adjuvant Therapy for Childhood Asthma and the Best Treatment Options. Am. J. Pediatr. 2019, 5(4), 291-298. doi: 10.11648/j.ajp.20190504.32

Copy | Download

AMA Style

Zhendong Yang, Xuding Sun, Jihong Wu, Gaojun Zhou, Yingyang Xu, et al. Exploration of Vitamin D Supplementation Adjuvant Therapy for Childhood Asthma and the Best Treatment Options. Am J Pediatr. 2019;5(4):291-298. doi: 10.11648/j.ajp.20190504.32

Copy | Download

@article{10.11648/j.ajp.20190504.32,
  author = {Zhendong Yang and Xuding Sun and Jihong Wu and Gaojun Zhou and Yingyang Xu and Xiong Xie and Kai Guan},
  title = {Exploration of Vitamin D Supplementation Adjuvant Therapy for Childhood Asthma and the Best Treatment Options},
  journal = {American Journal of Pediatrics},
  volume = {5},
  number = {4},
  pages = {291-298},
  doi = {10.11648/j.ajp.20190504.32},
  url = {https://doi.org/10.11648/j.ajp.20190504.32},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajp.20190504.32},
  abstract = {Vitamin D not only promotes the health of human bones and muscles but also has an important impact on the metabolism of extraskeletal tissues. As a steroid hormone, vitamin D possesses important physiological functions, including cell differentiation and proliferation and immune regulation. Research has shown that vitamin D insufficiency (VDI) or vitamin D deficiency (VDD) can make children susceptible to asthma. Vitamin D has important immunoregulatory functions associated with preventing the occurrence of asthma or the worsening of its symptoms, improving lung function and enhancing glucocorticoid (GCS) action. An increasing number of randomized controlled intervention studies have confirmed that vitamin D affects the occurrence and development of asthmatic diseases. In recent years, accumulating laboratory and clinical research has supported the use of vitamin D as an adjuvant treatment for asthma and has achieved good clinical results. But the clinical outcome of vitamin D in the treatment of asthma is not as impressive as experimental studies. In addition to the complexity of clinical research, it may be related to clinical application methods. In order to combine theory with clinical practice, focused on exploring and selecting the most effective vitamin D adjuvant treatment of asthma, and comprehensively optimizing and applying these methods is beneficial to improve the therapeutic effect. However, there are different opinions regarding the results of the studies.},
 year = {2019}
}

Copy | Download

TY  - JOUR
T1  - Exploration of Vitamin D Supplementation Adjuvant Therapy for Childhood Asthma and the Best Treatment Options
AU  - Zhendong Yang
AU  - Xuding Sun
AU  - Jihong Wu
AU  - Gaojun Zhou
AU  - Yingyang Xu
AU  - Xiong Xie
AU  - Kai Guan
Y1  - 2019/12/24
PY  - 2019
N1  - https://doi.org/10.11648/j.ajp.20190504.32
DO  - 10.11648/j.ajp.20190504.32
T2  - American Journal of Pediatrics
JF  - American Journal of Pediatrics
JO  - American Journal of Pediatrics
SP  - 291
EP  - 298
PB  - Science Publishing Group
SN  - 2472-0909
UR  - https://doi.org/10.11648/j.ajp.20190504.32
AB  - Vitamin D not only promotes the health of human bones and muscles but also has an important impact on the metabolism of extraskeletal tissues. As a steroid hormone, vitamin D possesses important physiological functions, including cell differentiation and proliferation and immune regulation. Research has shown that vitamin D insufficiency (VDI) or vitamin D deficiency (VDD) can make children susceptible to asthma. Vitamin D has important immunoregulatory functions associated with preventing the occurrence of asthma or the worsening of its symptoms, improving lung function and enhancing glucocorticoid (GCS) action. An increasing number of randomized controlled intervention studies have confirmed that vitamin D affects the occurrence and development of asthmatic diseases. In recent years, accumulating laboratory and clinical research has supported the use of vitamin D as an adjuvant treatment for asthma and has achieved good clinical results. But the clinical outcome of vitamin D in the treatment of asthma is not as impressive as experimental studies. In addition to the complexity of clinical research, it may be related to clinical application methods. In order to combine theory with clinical practice, focused on exploring and selecting the most effective vitamin D adjuvant treatment of asthma, and comprehensively optimizing and applying these methods is beneficial to improve the therapeutic effect. However, there are different opinions regarding the results of the studies.
VL  - 5
IS  - 4
ER  -

Copy | Download